000 | 02204 a2200565 4500 | ||
---|---|---|---|
005 | 20250515192620.0 | ||
264 | 0 | _c20100127 | |
008 | 201001s 0 0 eng d | ||
022 | _a1538-7755 | ||
024 | 7 |
_a10.1158/1055-9965.EPI-09-0611 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPrentice, Ross L | |
245 | 0 | 0 |
_aVariation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. _h[electronic resource] |
260 |
_bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _cNov 2009 |
||
300 |
_a3079-85 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aEstrogen Replacement Therapy |
650 | 0 | 4 |
_aEstrogens _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntrons _xgenetics |
650 | 0 | 4 | _aLinkage Disequilibrium |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
650 | 0 | 4 |
_aPostmenopause _xgenetics |
650 | 0 | 4 |
_aProgestins _xtherapeutic use |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 2 _xgenetics |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aHuang, Ying | |
700 | 1 | _aHinds, David A | |
700 | 1 | _aPeters, Ulrike | |
700 | 1 | _aPettinger, Mary | |
700 | 1 | _aCox, David R | |
700 | 1 | _aBeilharz, Erica | |
700 | 1 | _aChlebowski, Rowan T | |
700 | 1 | _aRossouw, Jacques E | |
700 | 1 | _aCaan, Bette | |
700 | 1 | _aBallinger, Dennis G | |
773 | 0 |
_tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _gvol. 18 _gno. 11 _gp. 3079-85 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1055-9965.EPI-09-0611 _zAvailable from publisher's website |
999 |
_c19251210 _d19251210 |